Kendra L Gully

9PUBLICATIONS
88CO-AUTHORS
Phylogeny and comparative analysisMedical virologyMolecular targetsVeterinary virologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Clade-3 Bat Sarbecovirus PRD0038 Reveals Constraints on Coronavirus Emergence and Immune Sensitivity.

|Aug 22, 2025
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation.

Diana M Battaglia, Claire E Post, Wenbo Yao

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

|Apr 11, 2023
1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity.

Aaron F Carlin, James R Beadle, Alex E Clark

|Jul 20, 2022
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.

Kenneth H Dinnon, Sarah R Leist, Kenichi Okuda

|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer, David R Martinez, John J Won

Pageof 2

Frequent Collaborators

7 joint publications

Ralph S Baric

3 joint publications

Lisa Gralinski

3 joint publications

Stephanie A Montgomery

3 joint publications

Stephanie Dong